May 26, 2016 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG) (“Alliance Growers” or the “Company”) is pleased to announce its ‘Four Pillars’ business organization. The Company has organized into four divisions: Marijuana for Medical Purposes Regulations (“MMPR”) licensed facilities, distribution networks, consumer products, and research and development – to focus Alliance Growers’ potential for success in the medical marijuana market.


Alliance holds a 50% interest in BC Maramed Production Ltd. (“BCMM”), which owns a leasehold interest and equipment for an 11,000 square foot production facility in Kelowna, British Columbia.  BCMM has submitted an application to become a Licensed Producer of medical marijuana under Health Canada’s MMPR program. Upon receipt by BCMM of an approved MMPR Production License from Health Canada, a further 12.5% interest in BCMM will be transferred to Alliance Growers.

Alliance Growers is being led through the MMPR license process by Rupert Shore with assistance from members of the Advisory board.   In addition to his duties as Director and Corporate Secretary for Alliance Growers, Rupert Shore, a practicing lawyer, is a member in good standing with the Law Society of British Columbia. He has been practicing law for 26 years and has been a sole practitioner focused on commercial litigation for the past 12 years.

Distribution Networks

The Company continues to look for attractive acquisition opportunities and commercial relationships. Charles Rendina, Regulatory and Financial Advisor to Alliance Growers, along with other members of the team, will be identifying and managing the opportunities for the US distribution network. Prior to joining Alliance, Mr. Rendina began researching the Washington state cannabis market from licensing and retail outlets to identification of the demand and trends of products being sold in Washington State. Mr. Redina is an International Business Lawyer, licensed to practice law in Washington and British Columbia, with over 26 years of experience advising business clients in both the USA and Canada on various cross border transactional matters. Mr. Rendina has provided advice and services negotiating mergers and acquisitions, negotiating and documenting significant loan transactions, intellectual property license agreements, private placements and other financings.

In addition to identifying acquisition opportunities in Washington State, Colorado and Oregon, Alliance is actively pursuing the purchase of dispensaries in Vancouver for distribution of medical Cannabis products.  Alliance has all the expertise it requires in its management and advisory members to be successful in this area.

Consumer Products

The Company is constantly seeking new accretive acquisition opportunities as well as commercial relationships for its Consumer Products division.  Alliance is currently in discussions with entities that will source, develop, distribute and sell cannabis related paraphernalia and edibles through retail establishments located in the emerging permitted US and Canadian markets. All members of the advisory board and management bring their respective consumer product resources to Alliance.  In addition to product acquisition, licensing and distribution, Alliance will be developing its own proprietary products under the guidance of Mr. Sina Pirooz, a Director and a compounding pharmacist.  Mr. Pirooz is a registered and practicing pharmacist and a professional member of the College of Pharmacists of British Columbia with over ten years of pharmaceuticals and pharmacy management experience. Mr. Shore will also be assisting with monitoring the current and proposed rules and regulations with regard to sales of medical cannabis and recreational cannabis products in both Canada and the US.

Research and Development

Under the guidance of one of Alliance Growers’ Directors, Sina Pirooz, the Company will be heavily engaged in research and development including certain product development involving his expertise in compounding pharmaceuticals. Mr. Pirooz, will also be a valuable asset for the Retail and Consumer Product divisions of the Company. As President of SP RX Services, an established pharmacy consulting company, Mr. Pirooz provides consulting, pharmacist and pharmacy management services to many of Canada’s largest and established drug store chains, pharmacy chains and independent pharmacies and drug stores, including Shoppers Drug Mart, Rexall Drugs, Pharmasave and Guardian Pharmacies.

Commenting on the organizational structure, Dennis Petke, Alliance Growers President and CEO said, “We are thrilled and proud of our growth over the past few months, having assembled a blue chip management team and identified several key opportunities for the Company to focus on. We anticipate rapid forward development and will update investors on our progress as we continue to expand into this exciting massive market.”

About Alliance Growers   

Alliance Growers Corp (ACG: CSE) is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – MMPR cannabis production facilities, distribution network, consumer products, and research and development. Alliance has advanced on its discussions regarding joint business interests and opportunities with PharmaGreen, including a potential full merger of PharmaGreen and Alliance Growers, subject to continued extensive due diligence and analysis. For further information please visit the Company’s corporate website at or the Company’s profile at

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to This email address is being protected from spambots. You need JavaScript enabled to view it.

About Pharmagreen

WFS Pharmagreen Inc. is a private company located in Mission, B.C. that is in the business of manufacturing and marketing cannabis-hemp based products for animals and owns the exclusive international rights to all present and future Canna Companion formulations and products. The Company’s executive management team and its advisory committee are composed of a significant mix of professionals that have been carefully gleaned from the fields of private and public company management; veterinary science; human medical science; marketing, branding and business development capped with unparalleled academic and celebrity endorsement. The Company’s animal products are developed under its 100% owned subsidiary Canna Companion Products, Inc. based in Washington State, U.S.A.  Canna operates a 5,000 sq. ft. facility for product formulation, fulfillment and customer care center in Monroe, Washington in support of its U.S. based sales for all levels, distributors, dealers, and e-commerce of the Canna Companion products, .

About DGWA

DGWA, the German Institute for Asset and Equity Allocation and Valuation, is a partner for the European Financial Markets – known and respected as one of the leading German Investment Banking Boutiques for providing global small and mid-cap Financial Advisory Services.

They build solid, substantial and comprehensive bridges for listed and non-listed companies to investors, financial institutions and multipliers like press and media and offer finest financial engineering solutions, tailor made for their clients.

DGWA’s management team runs a 25-year track record in trading, investing and analyzing SME’s around the world. It has been so far involved in over 250 IPO’s, financings, bond issues, dual listings and corporate finance transactions, as well as corresponding road shows and awareness campaigns.

DGWA is based in Frankfurt, home of the European Central Bank, centre of Europe’s financial activities and neighbours with various leading and specialized financial institutions – located in the heart of Europe and easily accessible via one of the largest airports in the world.

About the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse: FWB):

According to the FWB website, an estimated 45 percent of Europe’s top 300 companies have their primary listing on the London or Frankfurt exchanges.  The Frankfurt Stock Exchange is an international trading centre with more than 215 market participants, 50% of which are from countries other than Germany. The FWB is one of the world’s largest stock exchange for securities trading and ranks 10th in the “Trillion Dollar Club”. With 90 per cent of its turnover generated in Germany, namely at the two trading venues Xetra® and Börse Frankfurt, it is the largest of the seven regional securities exchanges in Germany.  Besides the specialist trading at Frankfurt Stock Exchange, its fully electronic trading system Xetra® is one of the leading electronic trading platforms in the world. With the launch of Xetra in 1997, the Frankfurt Stock Exchange strengthened its competitive position and created attractive framework conditions for foreign investors and market participants. The FWB was founded over four hundred years ago in 1685 and is operated by Deutsche Borse AG.

On behalf of the board of directors of


“Dennis Petke”
Dennis Petke
President and CEO

For more information contact:

Dennis Petke
Tel: 778-331-4266
This email address is being protected from spambots. You need JavaScript enabled to view it.

Rob Grace
Corporate Communications
Tel: 778-998-5431
This email address is being protected from spambots. You need JavaScript enabled to view it.


This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.